Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor

American Journal of Pathology

Volumn 153, Issue 6, 1998, Pages 1993-2006

  McLeskey, Sandra W ^a,b   Tobias, Christopher A ^a   Vezza, Phyllis R ^a,b   Filie, Armando C ^c   Kern, Francis G ^d   Hanfelt, John ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELL DEATH; CELL STRAIN MCF 7; GENE EXPRESSION; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR BLOOD FLOW; TUMOR GROWTH;

EID: 0031774306     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65713-6     Document Type: Article

References (49)

1. Gasparini G: Biological and clinical role of angiogenesis in breast cancer. Breast Cancer Res Treat 1995, 36:103-107
2. Baillie CT, Winslet MC, Bradley NJ: Tumour vasculature: a potential therapeutic target. Br J Cancer 1995, 72:257-267
3. Speir E, Sasse J, Shrivastav S, Casscells W: Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells. J Cell Physiol 1991, 147:362-373
4. Auerbach R, Auerbach W, Polakowski I: Assays for angiogenesis: a review. Pharmacol Ther 1991, 51:1-11
5. Liaw L, Schwartz SM: Comparison of gene expression in bovine aortic endothelium in vivo versus in vitro. Arterioscler Thromb 1993, 13:985-993
6. Craig LE, Spelman JP, Strandberg JD, Zink CM: Endothelial cells from diverse tissues exhibit differences in growth and morphology. Microvasc Res 1998, 55:65-76
7. McCarthy SA, Kuzu I, Gatter KC, Bicknell R: Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci 1991, 12:462-467
8. Yuan F, Leunig M, Berk DA, Jain RK: Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 1993, 45:269-289
9. Martin GR, Jain RK: Fluorescence ratio imaging measurement of pH gradients: calibration and application in normal and tumor tissues. Microvasc Res 1993, 46:216-230
10. McLeskey SW, Kurebayashi J, Honig SF, Zwiebel J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res 1993, 53:2168-2177
11. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, Kern FG: Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and LacZ. Cancer Res 1993, 53:2178-2187
12. Zhang L, Kharbanda S, Chen D, Bullocks J, Miller DL, Ding IYF, Hanfelt J, McLeskey SW, Kern FG: MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized metastatic tumors in ovariectomized or tamoxifen-treated nude mice. Oncogene 1997, 15: 2093-2108
13. Bullocks J, Zhang L, Ding IYF, McLeskey SW, Tobias CA, Miller DL, Kern FG: Overexpression of vascular endothelial cell growth factor (VEGF) in MCF-7 breast carcinoma cells facilitates growth in tamoxifen-treated nude mice and tumor cell dissemination. Proc Am Assoc Cancer Res 1997, 38:3521
14. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995, 36:169-180
15. McLeskey SW, Zhang L, Kharbanda S, Kurebayashi J, Lippman ME, Dickson RB, Kern FG: Fibroblast growth factor overexpressing breast carcinoma cells as models of angiogenesis and metastasis. Breast Cancer Res Treat 1996, 39:103-117
16. McLeskey SW, Zhang L, El-Ashry D, Trock BJ, Lopez CA, Kharbanda S, Tobias CA, Lorant LA, Hannum RS, Dickson RB, Kern FG: Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen, ICI 182,780, and two aromatase inhibitors. Clin Cancer Res 1998, 4:697-711
17. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, Dejana E: Monoclonal antibodies specific for endothelial cells of mouse blood vessels: their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 1994, 63:247-254
18. Carroll RJ, Ruppert D, Stefanski LA: Measurement Error in Nonlinear Models. London, Chapman and Hall, 1995
19. Cheng C-L, Van Ness JW: On estimating linear relationships when both variables are subject to errors. J Royal Statistical Soc 1994, 656:167-183
20. SAS Institute: SAS. Release 6.07. Cary, NC, SAS Institute, 1998
21. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, Jain RK: During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med 1996, 2:992-997
22. Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G: Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res 1996, 56:1111-1117
23. Deroanne CF, Hajitou A, Calberg-Bacq C-M, Nusgens BV, Lapière CM: Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res 1997, 57:5590-5597
24. Hajitou A, Deroanne CF, Noël A, Colette J, Nusgens BV, Foidart JM, Calberg-Bacq C-M: FGF-3 increases tumorigenicity in MCF7 breast cancer cells but FGF-4 effect is more pronounced and associated with VEGF upregulation. Proc Am Assoc Cancer Res 1998, 39:34
25. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P: Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 1998, 141:1659-1673
26. McLeskey SW, Zhang L, Trock BJ, Kharbanda S, Liu Y, Gottardis MM, Lippman ME, Kern FG: Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells. Br J Cancer 1996, 73:1053-1062
27. Weidner N, Moore DH II, Ljung B-M, Waldman FM, Goodson WHI, Mayall B, Chew K, Smith HS: Correlation of bromodeoxyuridine (BRDU) labeling of breast carcinoma cells with mitotic figure content and tumor grade. Am J Surg Pathol 1993, 17:987-994
28. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
29. Mundle SD, Raza A: The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis. Lab Invest 1995, 72:611-612
30. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: The two in situ techniques do not differentiate between apoptosis and necrosis but rather reveal distinct patterns of DNA fragmentation in apoptosis: reply. Lab Invest 1995, 72:612-613
31. Mundle S, Iftikhar A, Shetty V, Dameron S, Wright-Quinones V, Marcus B, Loew J, Gregory S, Raza A: Novel in situ double labeling for simultaneous detection of proliferation and apoptosis. J Histochem Cytochem 1994, 42:1533-1537
32. Raza A, Mundle S, Iftikhar A, Gregory S, Marcus B, Khan Z, Alvi S, Shetty V, Dameron S, Wright V, Adler S, Loew JM, Shott S, Ali SN, Preisler H: Simultaneous assessment of cell kinetics and programmed cell death in bone marrow biopsies of myelodysplastics reveals extensive apoptosis as the probable basis for ineffective hematopoiesis. Am J Hematol 1995, 48:143-154
33. Dickson RB, Bates SE, Valverius E, Knabbe C, Salomon D, Huff KK, Bronzert D, Walker-Jones D, Freter C, Favoni R, Yee D, Zugmaier G, Ennis B, Clarke R, Kern F, Rosen N, Lippman ME: Estrogen and antiestrogen regulation of mitogenic growth factors in human breast cancer cells. Prog Cancer Res Ther 1996, 35:217-222
34. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper W: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995, 91:755-763
35. Brandi ML, Crescioli C, Tanini A, Frediani U, Agnusdei D, Gennari C: Bone endothelial cells as eslrogen targets. Calcif Tissue Int 1993, 53:312-317
36. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS: Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 1994, 93:17-25
37. Glaser-Caulin T, Watson CA, Pardi R, Bender JR: Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 1996, 98:36-42
38. Gagliardi A, Collins DC: Inhibition of angiogenesis by antiestrogens. Cancer Res 1993, 53:533-535
39. Gagliardi A, Hennig B, Collins DC: Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res 1996, 16:1101-1106
40. Venkov CD, Rankin AB, Vaughan DE: Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function. Circulation 1996, 94:727-733
41. Lindner DJ, Borden EC: Effects of tamoxifen and interferon-β or the combination on tumor-induced angiogenesis. Int J Cancer 1997, 71:456-461
42. Naik P, Karrim J, Hanahan D: The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogeneic progenitors. Genes Dev 1996, 10:2105-2116
43. Rofstad EK: Growth and vascular structure of human melanoma xenografts. Cell Tissue Kinet 1984, 17:91-101
44. Fox SB, Gatter KC, Bicknell R, Going JJ, Stanton P, Cooke TG, Harris AL: Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993, 53:4161-4163
45. Forschen R, Classen S, Piontek M, Borchard F: Vascularization of carcinomas ot the esophagus and its correlation with tumor proliferation. Cancer Res 1994, 54:587-591
46. Brien SE, Zagzag D, Brem S: Rapid in situ cellular kinetics of intracerebral tumor angiogenesis using a monoclonal antibody to bromodeoxyuridine. Neurosurgery 1989, 25:715-719
47. Yoshii Y, Sugiyama K: Intercapillary distance in the proliferating area of human glioma. Cancer Res 1988, 48:2938-2941
48. Tannock IF: Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. Cancer Res 1970, 30:2470-2476
49. Bennett MH, Wilson GD, Dische S, Saunders MI, Martindale CA, Robinson BM, O'Halloran AE, Leslie MD, Laing JHE: Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma. Br J Cancer 1992, 65:870-878